These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 27883)

  • 1. Successful trans-maternal nadolol pharmacotherapy in a fetus presenting with long QT syndrome type 2 complicated by torsade de pointes.
    Shima Y; Horigome H; Nozaki Y; Lin L; Ishiodori T; Yano Y; Takahashi M; Murakami T; Yamasaki H; Takada H
    J Cardiol Cases; 2020 Dec; 22(6):265-268. PubMed ID: 33304417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of propranolol and nadolol on social defeat-induced behavioral impairments in rats.
    Zaidi S; Atrooz F; Valdez D; Liu H; Kochi C; Bond RA; Salim S
    Neurosci Lett; 2020 Apr; 725():134892. PubMed ID: 32165259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nadolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris.
    Heel RC; Brogden RN; Pakes GE; Speight TM; Avery GS
    Drugs; 1980 Jul; 20(1):1-23. PubMed ID: 6105067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorption of the beta-adrenergic-blocking agent, nadolol, by mice, rats, hamsters, rabbits, dogs, monkeys, and man: an unusual species difference.
    Dreyfuss J; Shaw JM; Ross JJ
    Xenobiotica; 1978 Aug; 8(8):503-8. PubMed ID: 29379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical safety evaluation of the nadolol/bendroflumethiazide combination in mice, rats, and dogs.
    Stevens AC; Keysser CH; Kulesza JS; Miller MM; Myhre JL; Sibley PL; Yoon YH; Keim GR
    Fundam Appl Toxicol; 1984 Jun; 4(3 Pt 1):360-9. PubMed ID: 6745529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Teratological study of talinolol (Cordanum, 02-115)].
    Wendler D; Schmidt W
    Pharmazie; 1975 Oct; 30(10):669-1. PubMed ID: 692
    [No Abstract]   [Full Text] [Related]  

  • 7. Carrageenan.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Jul; 31():79-94. PubMed ID: 6579019
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study on the chronic toxicity of 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane(talinolol, Cordanum, 02-115) in the rat and the beagle].
    Bartsch R; Merbt EM; Riedel H
    Pharmazie; 1975 Oct; 30(10):659-68. PubMed ID: 691
    [No Abstract]   [Full Text] [Related]  

  • 9. Preclinical toxicologic evaluation of nadolol, a new beta-adrenergic antagonist.
    Sibley PL; Keim GR; Kulesza JS; Murphy BF; Myhre JL; Parish HM; Yoon YH; Zaidi IH
    Toxicol Appl Pharmacol; 1978 May; 44(2):379-89. PubMed ID: 27883
    [No Abstract]   [Full Text] [Related]  

  • 10. Testosterone, testosterone oenanthate and testosterone propionate.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1979 Dec; 21():519-47. PubMed ID: 120842
    [No Abstract]   [Full Text] [Related]  

  • 11. Preclinical toxicity studies of naltrexone.
    Braude MC; Morrison JM
    NIDA Res Monogr; 1976 Sep; (9):16-26. PubMed ID: 826824
    [No Abstract]   [Full Text] [Related]  

  • 12. Preclinical toxicology of ifosfamide.
    Barnett D
    Semin Oncol; 1982 Dec; 9(4 Suppl 1):8-13. PubMed ID: 6761867
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.